For future investigations in order to further assess the impact on a PcnA label on obstetric patients, a clinical trial could be performed in which pregnant mothers with PcnA are given specific Pcn testing to assess whether they have a true allergy versus adverse drug side effects or other confounding factors. The gene discussed is PCNA; the disease is Allergy.